相关实验视频
Updated: Jun 12, 2025

07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.2K
瓦尔酸盐治疗后的指甲变化
S Shrestha1, A Pandey2, R Pathak3
1Department of Dermatology, Rapti Province Hospital, Dang, Tulsipur, Nepal.
Kathmandu University medical journal (KUMJ)
|September 27, 2024
概括
用于和情绪障碍的瓦尔酸很少会导致指甲变色和粗等变化. 这些罕见的指甲副作用在停止服用药物后是可逆的.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 临床医学 临床医学
背景情况:
- 瓦尔酸是治疗,双相情感障碍和偏头痛的常见药物.
- 瓦尔酸的副作用得到了充分的证据,但指甲变化很少被报告.
- 关于氨酸诱导的指甲异常现有的文献是有限的.
研究的目的:
- 为了记录和描述与酸 (酸) 使用相关的指甲变化.
- 为了确定这些指甲变化是否依赖于剂量或与治疗持续时间有关.
- 评估氨酸诱导的指甲异常的可逆性.
主要方法:
- 对临床病例的审查报告在酸治疗期间指甲变化.
- 临床检查和指甲异常的摄影记录.
- 分析患者数据,包括患者的年龄,剂量和治疗时间.
主要成果:
- 据报道的指甲变化包括色,色,指甲粗,棕黄色变色和横向黄色带.
- 这些指甲异常发生不论患者的年龄,酸剂量或治疗持续时间.
- 在报告的病例中,在停止使用瓦尔酸后,指甲的变化消失了.
结论:
- 瓦尔酸很少会导致指甲变化的频谱.
- 这些指甲变化的发生与已确定的药理动力学因素 (如剂量或持续时间) 无关.
- 迅速识别和停止使用烯酸会导致指甲异常的逆转.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149
Endocarditis II: Clinical features and Diagnostic Tests
2
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
266
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
266
Antiepileptic Drugs: GABAergic Pathway Potentiators
341
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
341
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Mania and Antimanic Drugs: Overview
148
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
148

